Predictive factors for complications in endoscopic resection of large colorectal lesions: a multicenter prospective study

Wada, Yoshiki; Kudo, Shin‐ei; Tanaka, Shinji; Saito, Yutaka; Iishii, Hiroyasu; Ikematsu, Hiroaki; Igarashi, Masahiro; Saitoh, Yusuke; Inoue, Yoshio; Kobayashi, Kiyonori; Hisabe, Takashi; Takahashi, Osamu; Kashida, Hiroshi; Ishikawa, Hideki; Sugihara, Kenichi

doi:10.1007/s00464-014-3799-9

Cited by 21 publications

(12 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, these definitions have not been established on the basis of solid evidence. With regard to frequency of these accidental complications, perforation rates during endoscopic resection are reported to be 0%, 0–0.8% and 2.0–10.7% for polypectomy, EMR, and ESD, respectively, according to recent publications (Table ) …”

Section: Complications During Proceduresmentioning

confidence: 99%

See 1 more Smart Citation

Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection

Tanaka

Kashida

Saito

et al. 2019

Digestive Endoscopy

Self Cite

275

292

View full text Add to dashboard Cite

Suitable lesions for endoscopic treatment include not only early colorectal carcinomas but also several types of precarcinomatous adenomas. It is important to establish practical guidelines wherein preoperative diagnosis of colorectal neoplasia and selection of endoscopic treatment procedures are appropriately outlined and to ensure that actual endoscopic treatment is useful and safe in general hospitals when carried out in accordance with guidelines. In cooperation with the Japanese Society for Cancer of the Colon and Rectum, the Japanese Society of Coloproctology, and the Japanese Society of Gastroenterology, the Japan Gastroenterological Endoscopy Society compiled colorectal endoscopic submucosal dissection/endoscopic mucosal resection guidelines by using evidence‐based methods in 2014. The first edition of these guidelines was published 5 years ago. Accordingly, we have published the second edition of these guidelines based on recent new knowledge and evidence.

show abstract

Section: Complications During Proceduresmentioning

confidence: 99%

“…With regard to frequency of these accidental complications, perforation rates during endoscopic resection are reported to be 0%, 0-0.8% and 2.0-10.7% for polypectomy, EMR, and ESD, respectively, according to recent publications (Table 3). 48,111,[131][132][133][134]…”

Section: Endoscopic Treatment For Lesions Positive For the Nonliftingmentioning

confidence: 99%

Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection

Tanaka

Kashida

Saito

et al. 2019

Digestive Endoscopy

Self Cite

275

292

View full text Add to dashboard Cite

show abstract

“…• Endoscopic resection for lesions with a maximum diameter of 2 cm or more includes EMR, piecemeal EMR, and ESD [33, [269][270][271][272]].…”

mentioning

confidence: 99%

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

et al. 2019

Self Cite

View full text Add to dashboard Cite

The number of deaths from colorectal cancer in Japan continues to increase. Colorectal cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of treatments was performed, with corrections and additions made based on knowledge acquired since the 2016 version (drug therapy) and the 2014 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum guidelines 2019 for the treatment of colorectal cancer (JSCCR guidelines 2019) have been prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment and to deepen mutual understanding between healthcare professionals and patients by making these guidelines available to the general public. These guidelines have been prepared by consensuses reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. Controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here, we present the English version of the JSCCR guidelines 2019.

show abstract

“…Patient-related delayed bleeding factors have been described, such as age (33,34), the presence of diverticulosis (35), and hypertension (36), but the results are contradictory (31). Factors related to immediate bleeding have also been described, such as age, and cardiovascular or chronic renal disease (27).…”

Section: Patient- Polyp- and Technique-related Risk Factorsmentioning

confidence: 99%

Endoscopic resection of colorectal polyps in patients on antiplatelet therapy: an evidence-based guidance for clinicians

et al. 2016

View full text Add to dashboard Cite

Due to the rising prevalence of coronary heart disease, endoscopists are more frequently performing a polypectomy in patients on antiplatelet therapy (APT) and dual antiplatelet therapy (DATP). Despite the availability of several guidelines with regard to the management of antiplatelet drugs during the periprocedure period, there is still variability in the current clinical practice. This may be influenced by the low quality of the evidence supporting recommendations, because most of the studies dealing with APT and polypectomy are observational and retrospective, and include mainly small (< 10 mm) polyps. However, some recommendations can still be made. An estimation of the bleeding and thrombotic risk of the patient should be made in advance. In the case of DAPT the procedure should be postponed, at least until clopidogrel can be safely withheld. If possible, non-aspirin antiplatelet drugs should be withheld 5-7 days before the procedure. Polyp size is the main factor related with post-polypectomy bleeding and it is the factor that should drive clinical decisions regarding the resection method and the use of endoscopic prophylactic measures. Non-aspirin antiplatelet agents can be reintroduced 24-48 hours after the procedure. In conclusion, there is little data with regard to the management of DAPT in patients with a scheduled polypectomy. Large randomized controlled trials are needed to support clinical recommendations.

show abstract

Predictive factors for complications in endoscopic resection of large colorectal lesions: a multicenter prospective study

Cited by 21 publications

References 28 publications

Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection

Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

Endoscopic resection of colorectal polyps in patients on antiplatelet therapy: an evidence-based guidance for clinicians

Contact Info

Product

Resources

About